Project Number 5P50AG005136-30 Agency/Funding Organization NIA Funding Year 2013 View Full Project Details for MODULATION OF ABETA PEPTIDE ACCUMULATION AND NEURON DAMAGE IN VIVO WITH ADULT BON Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator KEENE, CHRISTOPHER DIRK Principal Investigator First Name CHRISTOPHER DIRK Principal Investigator Last Name KEENE Awardee Organization UNIVERSITY OF WASHINGTON Awardee State Washington Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-10-002: ALZHEIMER'S DISEASE RESEARCH CENTERS (P50) FY Overall Cost $180,062 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) University of Washington Alzheimer's Disease Research Center National Alzheimer's Coordinating Center (NACC) [AlzPED] Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model Pagination Page 1 Next page ››
